Hologic Inc (HOLX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$62.01

Buy

$63.98

arrow-down$-0.16 (-0.26%)

Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Its products are used in diagnosis of human diseases and screen donated human blood and plasma.
Prices updated at 02 Jun 2025, 21:40 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.67%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Stephen P. Macmillan
CEO
Mr. Stephen P. Macmillan
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
7,063
Head office
250 Campus Drive
Marlborough
United States
01752
mobile
+1 508 263-2900
letter
ryan.simon@hologic.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Scott T. Garrett
Independent Director
0.11m--0.35m-
Dr. Martin D. Madaus,PhD
Director
-----
Ms. Sally Wellinghoff Crawford
Independent Director
0.12m--0.36m-
Mr. Wayde D. McMillan
Director
-----
Mr. Charles J. Dockendorff
Independent Director
0.12m--0.35m-
Ms. Diana De Walt
Senior Vice President, Human Resources
-----
Mr. Stephen P. Macmillan
Chairman of the Board, Chief Executive Officer and President
1.21m--15.82m-
Ms. Amy A. Wendell
Lead Independent Director
0.12m--0.36m-
Ms. Karleen M. Oberton
Chief Financial Officer
0.69m--4.09m-
Ms. Stacey D. Stewart
Independent Director
0.09m--0.33m-
Dr. Ludwig N. Hantson, PhD
Independent Director
0.09m--0.33m-
Ms. Christiana Stamoulis, M.B.A.
Independent Director
0.09m--0.33m-
Mr. Benjamin J. Cohn
Vice President, Corporate Controller and Principal Accounting Officer
-----
Mr. Essex D. Mitchell
Chief Operating Officer
0.59m--4.08m-
Mr. Jan Verstreken
Group President, International
0.69m--3.59m-
Ms. Jennifer Schneiders
President, Diagnostics Solutions
-----
Ms. Nanaz Mohtashami
Independent Director
0.09m--0.33m-
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
-----
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc26,815,5190.02995-78119-0.29047431 May 202512.03
BlackRock Inc21,364,8330.02772-861238-3.874931 May 20259.59
T. Rowe Price Investment Management,Inc.17,688,4780.72279-250355-1.39560431 May 20257.94
T. Rowe Price12,663,17610.43715-2929007-31 May 20255.68
Morgan Stanley - Brokerage Accounts10,208,7820.04509-289751-2.75991931 May 20254.58

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
13 Dec 2024-Mr. Brandon Schnittker73.656,6296,163--
09 Dec 2024-Dr. Martin D. Madaus,PhD--342--
04 Dec 2024-Mr. Essex D. Mitchell-----
04 Dec 2024-Mr. Essex D. Mitchell76.341,897,48227,957--
04 Dec 2024-Mr. Essex D. Mitchell71.13634,12452,813--
04 Dec 2024-Mr. Essex D. Mitchell68.35512,96743,898--
04 Dec 2024-Mr. Essex D. Mitchell40.9780,13731,867--
04 Dec 2024-Mr. Essex D. Mitchell45.61206,43136,393--
04 Dec 2024-Mr. Essex D. Mitchell--2,972--
04 Dec 2024-Mr. Essex D. Mitchell-----
04 Dec 2024-Mr. Essex D. Mitchell-----
14 Nov 2024-Mr. Stephen P. Macmillan77.54531,9241,234,278--
14 Nov 2024-Ms. Karleen M. Oberton77.54103,283102,108--
14 Nov 2024-Mr. John M. Griffin77.5486,845182,514--
14 Nov 2024-Mr. Benjamin J. Cohn77.548,52911,250--
14 Nov 2024-Mr. Essex D. Mitchell77.54103,98129,911--
14 Nov 2024-Mr. Erik Anderson77.5430,24123,231--
14 Nov 2024-Mr. Jan Verstreken77.5448,850103,814--
14 Nov 2024-Ms. Jennifer Schneiders77.5439,31312,096--
14 Nov 2024-Mr. Brandon Schnittker77.5413,8026,253--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.